Philip Comp to Male
This is a "connection" page, showing publications Philip Comp has written about Male.
Connection Strength
0.245
-
Phosphofructokinase deficiency and portal and mesenteric vein thrombosis. Am J Med Sci. 2011 May; 341(5):417-9.
Score: 0.032
-
An association between plasma free protein s concentration and risk of coronary heart disease in middle-aged men. Thromb Res. 2001 Jan 15; 101(2):1-11.
Score: 0.016
-
A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement: The Danaparoid Hip Arthroplasty Investigators Group. Orthopedics. 1998 Oct; 21(10):1123-8.
Score: 0.013
-
Activated factor VII levels in patients with angiographically confirmed coronary artery disease. Am J Cardiol. 1997 Jul 15; 80(2):217-9.
Score: 0.012
-
Progression of an untreated pseudotumor. Haemophilia. 2017 09; 23(5):e464-e466.
Score: 0.012
-
Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study Group. Am J Cardiol. 1996 Nov 01; 78(9):1074-6.
Score: 0.012
-
Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis. Thromb Res. 2015 Dec; 136(6):1120-5.
Score: 0.011
-
Effect of treatment with low-dose warfarin-aspirin on activated factor VII. Blood. 1995 Jun 01; 85(11):3034-9.
Score: 0.011
-
Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 1993 Feb 01; 81(3):734-44.
Score: 0.009
-
Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study. Thromb Res. 2012 Sep; 130(3):381-9.
Score: 0.009
-
Free protein S levels are elevated in familial C4b-binding protein deficiency. Blood. 1990 Dec 15; 76(12):2527-9.
Score: 0.008
-
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty. 2009 Jan; 24(1):1-9.
Score: 0.006
-
Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosis. Arteriosclerosis. 1987 Sep-Oct; 7(5):456-62.
Score: 0.006
-
Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost. 2007 Sep; 5(9):1854-61.
Score: 0.006
-
Oral contraceptives and gender affect protein S status. Blood. 1987 Feb; 69(2):692-4.
Score: 0.006
-
The relationship between arterial elasticity and metabolic syndrome features. Angiology. 2007 Feb-Mar; 58(1):5-10.
Score: 0.006
-
The regulation of hemostasis: the protein C system. N Engl J Med. 1986 May 15; 314(20):1298-304.
Score: 0.006
-
Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am. 2005 Oct; 87(10):2169-77.
Score: 0.005
-
Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost. 2005 May; 3(5):962-8.
Score: 0.005
-
Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med. 1984 Dec 13; 311(24):1525-8.
Score: 0.005
-
Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest. 1984 Dec; 74(6):2082-8.
Score: 0.005
-
Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex. Blood. 1984 Jan; 63(1):15-21.
Score: 0.005
-
Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med. 2003 Oct 30; 349(18):1703-12.
Score: 0.005
-
Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study. Vasc Endovascular Surg. 2002 Mar-Apr; 36(2):83-91.
Score: 0.004
-
Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation. 2001 Jul 03; 104(1):74-8.
Score: 0.004
-
Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility. Arch Intern Med. 2000 Feb 14; 160(3):309-13.
Score: 0.004
-
Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis. J Rheumatol. 2000 Feb; 27(2):384-90.
Score: 0.004
-
The dilute whole blood clot lysis assay: a screening method for identifying postoperative patients with a high incidence of deep venous thrombosis. J Lab Clin Med. 1979 Jan; 93(1):120-7.
Score: 0.003
-
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med. 1998 Jan 01; 128(1):1-7.
Score: 0.003
-
PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost. 1998; 24(2):195-202.
Score: 0.003
-
Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy. Atherosclerosis. 1995 Apr 24; 114(2):203-11.
Score: 0.003
-
Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group. Am J Cardiol. 1994 Oct 01; 74(7):657-61.
Score: 0.003
-
Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective plasma low-density lipoprotein removal. Am J Cardiol. 1993 Apr 01; 71(10):816-22.
Score: 0.002
-
Afibrinogenemia and hypobetalipoproteinemia in a kindred. Arch Intern Med. 1991 Apr; 151(4):800-4.
Score: 0.002